POCARE
Live / Allowed — Notice of allowance issued (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99016338
- Mark type
- Stylized text
- Filed
- 23 Jan 2025
- Published for opposition
- 27 Jan 2026
- Attorney of record
- JACQUELINE ZION
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; development of cell therapy products; development of technologies for the manufacture and processing of cells to be used as part of advance cell therapies
Owner
- OCTOMERA LLC, Baltimore, MD, US
- OCTOMERA LLC, Baltimore, MD, US
Prosecution history
- 24 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jan 2026 — PUBLISHED FOR OPPOSITION
- 21 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Dec 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 08 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Oct 2025 — FINAL REFUSAL E-MAILED
- 08 Oct 2025 — FINAL REFUSAL WRITTEN
- 03 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED